PROCEPT BioRobotics pre-announces Q4 rev ~$23.6-23.8M, FY2022 rev ~$74.8-75.0M (+117% YoY)

PROCEPT BioRobotics Corp

2022-FY EPS reported -$1.96 revenue$75,014,000

Q4 2022 revenue expected $23.6M-$23.8M, up from $10.1M in Q4 2021.
U.S. system sales of 28 robots generating ~$10.4M-$10.5M in Q4 system revenue.
U.S. handpiece and consumables revenue ~$10.2M-$10.4M in Q4 2022.
Full-year 2022 revenue ~$74.8M-$75.0M, ~117% growth over FY2021.
Full financial results to be reported on February 28, 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PROCEPT BioRobotics Corp reported the quarter and fiscal year ended December 31, 2022 results: revenue $74.8 million to $75.0 million.

Period: the quarter and fiscal year ended December 31, 2022
Revenue: $74.8 million to $75.0 million
Result: preliminary results

Exact text from the filing

the fourth quarter of 2022 o Total international revenue of approximately $2.0 million for the fourth quarter of 2022 • Fiscal year 2022 revenue is expected to be approximately $74.8 million to $75.0 million, representing growth of approximately 117% compared to the prior year period The Company plans to report financial results for the fourth quarter and fiscal year

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

PROCEPT BioRobotics Corp filing history →

Source: SEC EDGAR

accession 0001628280-23-000731

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.